Common Contracts
3 similar Note and Warrant Purchase Agreement contracts by Amicus Therapeutics Inc
EX-10.1 3 a16-4879_1ex10d1.htm EX-10.1 NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • May 5th, 2020 • Delaware
THIS NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of February 19, 2016 (the “Effective Date”) by and among Amicus Therapeutics, Inc. (“Amicus” or the “Company”), a Delaware corporation with its principal place of business at 1 Cedar Brook Drive, Cranbury, New Jersey 08512, Amicus Therapeutics UK Limited (“Amicus UK,” and together with the Company, the “Companies”), a private limited company incorporated under the laws of England and Wales with company number 05541527 and its principal place of business at Phoenix House, Oxford Road, Tatling End, Gerrards Cross, Buckinghamshire SL9 7AP United Kingdom, and each Purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • February 22nd, 2016 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
Trading Days beginning immediately prior to the date of issuance of the Notes, provided that if such result is less than $6.00 it shall be deemed to be $6.00 and if such result is more than $7.00 it shall be deemed to be $7.00, and (y) 132.5%, subject to adjustment pursuant to Section 4 below. For any Warrants issued pursuant to Additional Notes, the exercise price shall be the product of (x) the VWAP for the four (4) Trading Days beginning immediately prior to the date of issuance of such Additional Notes, and (y) 132.5%, subject to adjustment pursuant to Section 4 below.
NOTE AND WARRANT PURCHASE AGREEMENTNote and Warrant Purchase Agreement • October 1st, 2015 • Amicus Therapeutics Inc • Pharmaceutical preparations • Delaware
THIS NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”) is made as of October 1, 2015 (the “Effective Date”) by and among Amicus Therapeutics, Inc. (“Amicus”), a Delaware corporation with its principal place of business at 1 Cedar Brook Drive, Cranbury, New Jersey 08512, and each Purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
